A Randomized Controlled Trial of HER-2 Positive Breast Cancer Patients Treated With Lapatinib vs Herceptin
Clinical trial NCT03085368 · UNKNOWN
Trial details
- NCT number
- NCT03085368
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-01
- Primary completion
- 2018-05-01
- Enrollment
- 482
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.